The pesticide distributor posted a sharp revenue jump year-on-year, but a deeper net loss and margin squeeze highlight persistent operational challenges.
India Pesticides saw revenue leap 61.5% in Q1 FY27, yet its net loss widened to ₹0.52 crore. The quarter reveals a business struggling with profitability despite top-line growth, as margins remain under severe pressure.
For a trading company like India Pesticides, the story is written in the spread between what it buys and sells. The first quarter of FY27 delivered a dramatic top-line jump, but the bottom line fell further into the red, showing that cost pressures are biting harder than sales can cover.
Revenue for the quarter ended June 2026 came in at ₹16.65 crore, a sharp 61.5% increase from the same period last year. However, the net loss widened to ₹0.52 crore, deepening by 64.4% year-on-year. Sequentially, both revenue and profit fell from the March quarter.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Period | Quarter ended June 2026 | Quarter ended March 2026 | Quarter ended June 2025 |
| Revenue (₹ Cr) | 16.65YoY +61% | 17.75 | 10.31 |
| Profit (₹ Cr) | -0.52YoY +64% | -6.25 | -1.46 |
| Net Profit Margin (%) | -3.1YoY +78% | -35.2 | -14.2 |
A revenue jump of this magnitude typically signals strong demand or pricing power. For India Pesticides, the growth appears driven by higher sales volumes or value, but it wasn't enough to overcome a fundamental profitability problem. The net profit margin, though improved from the disastrous prior quarter, remains negative at -3.1%.
Research from StockWatch suggests the broader pesticide distribution industry is facing a tough environment. Competition remains intense, and pricing is closely contested, limiting the ability to pass on higher costs. For a pure trading business, this creates a persistent squeeze on gross margins.
With the company guiding for only lower single-digit growth for the full year, as noted in its earnings call, the near-term path to profitability is narrow. The focus shifts squarely to managing the spread between purchase and sale prices. Any relief will depend on easing input costs or achieving better terms with suppliers and customers.
Live Chart
· PBGLOBAL
(BSE)
ISIN: INE615W01011
The company's long-term ₹1,000 crore capex plan for its Hamirpur facility, mentioned in reports, is a multi-year bet on backward integration and new products. But for now, the core trading business must navigate a challenging margin landscape.
Key Points
The quarter presents a clear dichotomy: impressive revenue growth paired with deteriorating profitability. This is the hallmark of a margin squeeze, where the cost of goods sold is rising faster than selling prices can adjust.
For India Pesticides, the path forward is less about chasing sales and more about defending its gross margin. The success of its long-term capex and product diversification will take years to materialize. Investors are left weighing whether the current trading model can be stabilized before those future bets pay off.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.